2024 Q3 Form 10-Q Financial Statement

#000095017024127101 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $1.100M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.55M
YoY Change 41.44%
% of Gross Profit
Research & Development $14.72M
YoY Change 56.34%
% of Gross Profit
Depreciation & Amortization $14.50M
YoY Change -23.68%
% of Gross Profit
Operating Expenses $66.65M
YoY Change 13.03%
Operating Profit
YoY Change
Interest Expense $1.410M
YoY Change 40.72%
% of Operating Profit
Other Income/Expense, Net -$236.9M
YoY Change -2892.5%
Pretax Income -$302.4M
YoY Change 499.09%
Income Tax $646.0K
% Of Pretax Income
Net Earnings -$171.9M
YoY Change 722.35%
Net Earnings / Revenue -15631.45%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.11
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $516.4M
YoY Change 287.36%
Cash & Equivalents $516.4M
Short-Term Investments
Other Short-Term Assets $19.66M
YoY Change -6.74%
Inventory
Prepaid Expenses $7.073M
Receivables
Other Receivables
Total Short-Term Assets $545.6M
YoY Change 234.59%
LONG-TERM ASSETS
Property, Plant & Equipment $260.1M
YoY Change 15.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.872M
YoY Change -73.87%
Total Long-Term Assets $276.0M
YoY Change 15.46%
TOTAL ASSETS
Total Short-Term Assets $545.6M
Total Long-Term Assets $276.0M
Total Assets $821.6M
YoY Change 104.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.962M
YoY Change 14.74%
Accrued Expenses $18.01M
YoY Change -5.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $44.64M
YoY Change 17825.7%
Total Short-Term Liabilities $94.08M
YoY Change 249.72%
LONG-TERM LIABILITIES
Long-Term Debt $156.3M
YoY Change 166.93%
Other Long-Term Liabilities $68.52M
YoY Change 132.49%
Total Long-Term Liabilities $156.3M
YoY Change 166.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $94.08M
Total Long-Term Liabilities $156.3M
Total Liabilities $318.8M
YoY Change 177.48%
SHAREHOLDERS EQUITY
Retained Earnings -$453.9M
YoY Change 187.75%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $308.9M
YoY Change
Total Liabilities & Shareholders Equity $821.6M
YoY Change 104.32%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$171.9M
YoY Change 722.35%
Depreciation, Depletion And Amortization $14.50M
YoY Change -23.68%
Cash From Operating Activities -$33.43M
YoY Change -7.28%
INVESTING ACTIVITIES
Capital Expenditures $30.32M
YoY Change -58.74%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$30.32M
YoY Change -58.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 294.7M
YoY Change 448.34%
NET CHANGE
Cash From Operating Activities -33.43M
Cash From Investing Activities -30.32M
Cash From Financing Activities 294.7M
Net Change In Cash 230.9M
YoY Change -513.84%
FREE CASH FLOW
Cash From Operating Activities -$33.43M
Capital Expenditures $30.32M
Free Cash Flow -$63.75M
YoY Change -41.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001780312
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39040
dei Entity Registrant Name
EntityRegistrantName
AST SPACEMOBILE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-2027232
dei Entity Address Address Line1
EntityAddressAddressLine1
Midland Intl. Air & Space Port
dei Entity Address Address Line2
EntityAddressAddressLine2
2901 Enterprise Lane
dei Entity Address City Or Town
EntityAddressCityOrTown
Midland
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
79706
dei City Area Code
CityAreaCode
432
dei Local Phone Number
LocalPhoneNumber
276-3966
dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
ASTS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
516389000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85622000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
2497000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2475000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7073000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4591000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
19662000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
14194000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
545621000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
106882000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
260068000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238478000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12088000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13221000
CY2024Q3 asts Other Non Current Assets
OtherNonCurrentAssets
3872000
CY2023Q4 asts Other Non Current Assets
OtherNonCurrentAssets
2311000
CY2024Q3 us-gaap Assets
Assets
821649000
CY2023Q4 us-gaap Assets
Assets
360892000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8962000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20575000
CY2024Q3 asts Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
16480000
CY2023Q4 asts Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
23926000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
22468000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1534000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1468000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
44635000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
252000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
94079000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
46221000
CY2024Q3 asts Warrant Liabilities
WarrantLiabilities
57460000
CY2023Q4 asts Warrant Liabilities
WarrantLiabilities
29960000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11057000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11900000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
156252000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
59252000
CY2024Q3 us-gaap Liabilities
Liabilities
318848000
CY2023Q4 us-gaap Liabilities
Liabilities
147333000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
762426000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
288404000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
353000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
227000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-453888000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189662000
CY2024Q3 us-gaap Minority Interest
MinorityInterest
193881000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
114568000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
502801000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
213559000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
821649000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
360892000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1100000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2500000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2024Q3 us-gaap Other General Expense
OtherGeneralExpense
21828000
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
19523000
us-gaap Other General Expense
OtherGeneralExpense
62546000
us-gaap Other General Expense
OtherGeneralExpense
58818000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15551000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10995000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45677000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31073000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14724000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9418000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23435000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36721000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14543000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19029000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
54880000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
34877000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
66646000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
58965000
us-gaap Operating Expenses
OperatingExpenses
186538000
us-gaap Operating Expenses
OperatingExpenses
161489000
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
236912000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7481000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
284839000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-21454000
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1386000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
495000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5846000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4311000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1410000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
507000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1661000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10237000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-236888000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8483000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-289024000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15528000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-302434000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50482000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-473062000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-145961000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
646000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
266000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1172000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-408000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-303080000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-50748000
us-gaap Profit Loss
ProfitLoss
-474234000
us-gaap Profit Loss
ProfitLoss
-145553000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-131134000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-29839000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-210008000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-89918000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-171946000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-20909000
us-gaap Net Income Loss
NetIncomeLoss
-264226000
us-gaap Net Income Loss
NetIncomeLoss
-55635000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-303080000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-50748000
us-gaap Profit Loss
ProfitLoss
-474234000
us-gaap Profit Loss
ProfitLoss
-145553000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
529000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-358000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
190000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-526000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
529000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-358000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
190000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-526000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-302551000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-51106000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-474044000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-146079000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-130906000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-30050000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-209944000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-90226000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-171645000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21056000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-264100000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-55853000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
241870000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6810000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
144876000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2953000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-2085000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
410928000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
529000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-303080000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
502801000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
213559000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20617000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
332008000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3058000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-3325000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
410928000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
190000
us-gaap Profit Loss
ProfitLoss
-474234000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
502801000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
335877000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2589000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-91000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
45000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-92000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-358000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-50748000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
287222000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
359826000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10595000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
63476000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
225000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-821000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-526000
us-gaap Profit Loss
ProfitLoss
-145553000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
287222000
us-gaap Profit Loss
ProfitLoss
-474234000
us-gaap Profit Loss
ProfitLoss
-145553000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54880000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34877000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3047000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
374000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2221000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
284839000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-21454000
us-gaap Share Based Compensation
ShareBasedCompensation
20617000
us-gaap Share Based Compensation
ShareBasedCompensation
10595000
us-gaap Paid In Kind Interest
PaidInKindInterest
2959000
us-gaap Paid In Kind Interest
PaidInKindInterest
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7940000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1601000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7998000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6215000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
357000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
54000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
22468000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1081000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1680000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-97703000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-124041000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92095000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
96462000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92095000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96462000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
145000000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
63500000
us-gaap Repayments Of Debt
RepaymentsOfDebt
187000
us-gaap Repayments Of Debt
RepaymentsOfDebt
180000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9435000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9653000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
338911000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
65003000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
6903000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1527000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
153307000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3058000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
225000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3325000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
620426000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117368000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-395000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
430789000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-103530000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88097000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
239256000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
518886000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
135726000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6709000
asts Purchases Of Property And Equipment In Accounts Payable And Accrued Expense
PurchasesOfPropertyAndEquipmentInAccountsPayableAndAccruedExpense
5086000
asts Purchases Of Property And Equipment In Accounts Payable And Accrued Expense
PurchasesOfPropertyAndEquipmentInAccountsPayableAndAccruedExpense
7120000
asts Pik Interest Paid Through Issuance Of Pik Notes
PikInterestPaidThroughIssuanceOfPikNotes
2959000
asts Pik Interest Paid Through Issuance Of Pik Notes
PikInterestPaidThroughIssuanceOfPikNotes
0
asts Settlement Of Warrant Liabilities By Issuing Shares
SettlementOfWarrantLiabilitiesByIssuingShares
257337000
asts Settlement Of Warrant Liabilities By Issuing Shares
SettlementOfWarrantLiabilitiesByIssuingShares
0
us-gaap Interest Paid Net
InterestPaidNet
6694000
us-gaap Interest Paid Net
InterestPaidNet
1071000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1135000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
510000
CY2024Q3 asts Set Of Patents
SetOfPatents
36
CY2024Q3 asts Number Of Patent Pending Claims
NumberOfPatentPendingClaims
3450
CY2024Q3 asts Number Of Patent Granted
NumberOfPatentGranted
1390
asts Nature Of Operations Description
NatureOfOperationsDescription
The Company operates from multiple locations that include its corporate headquarters and 185,000 square feet AIT facilities in Texas where the final AIT is performed, and engineering and development centers elsewhere in the United States, and in India, Scotland, Spain, and Israel.
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company bases its estimates and assumptions on historical experience when available and on other market-specific or other relevant assumptions that it believes to be reasonable under the circumstances. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, useful lives assigned to property and equipment, the fair values of warrant liabilities, potential impairment of long-lived assets, and equity-based compensation expense. The Company assesses estimates on an ongoing basis; however, actual results could materially differ from those estimates which could have a material impact on the Company’s financial position or results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s significant accounting policies are described in Note 2: Summary of Significant Accounting Policies of the 2023 Annual Report on Form 10-K, and there have been no significant changes in these significant accounting policies as compared to those described therein.</span>
CY2024Q3 us-gaap Revenues
Revenues
1100000
us-gaap Revenues
Revenues
2500000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
22500000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
518900000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88100000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
430300000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
69700000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
2500000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
2500000
CY2024Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y6M3D
CY2023Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P2Y3M3D
CY2024Q3 asts Property Plant And Equipment Net Exculed Construction In Progress
PropertyPlantAndEquipmentNetExculedConstructionInProgress
373984000
CY2023Q4 asts Property Plant And Equipment Net Exculed Construction In Progress
PropertyPlantAndEquipmentNetExculedConstructionInProgress
299651000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
113916000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
61173000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
260068000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238478000
us-gaap Depreciation
Depreciation
54900000
us-gaap Depreciation
Depreciation
34900000
CY2024Q3 us-gaap Depreciation
Depreciation
14500000
CY2023Q3 us-gaap Depreciation
Depreciation
19000000
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
147959000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0
CY2024Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
52023000
CY2023Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
52023000
CY2024Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000
CY2024Q3 asts Debt Instrument Carrying Amount For Total
DebtInstrumentCarryingAmountForTotal
4571000
CY2023Q4 asts Debt Instrument Carrying Amount For Total
DebtInstrumentCarryingAmountForTotal
4758000
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
219553000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
71781000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
44635000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
252000
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
18666000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
12277000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
156252000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
59252000
asts Debt Issuance Costs Exit Fee
DebtIssuanceCostsExitFee
3500000
CY2024Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
757100000
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
68700000
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
5400000
us-gaap Interest Expense Debt
InterestExpenseDebt
14700000
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1100000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3000000
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1400000
us-gaap Interest Expense Debt
InterestExpenseDebt
1500000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
400000
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
400000
us-gaap Debt Instrument Restrictive Covenants
DebtInstrumentRestrictiveCovenants
As of September 30, 2024, the Company was in compliance with all debt covenants requirements, subject to the mandatory prepayment of the Senior Secured Credit Facility Loan related to raising capital from the issuance of equity interests in excess of the defined threshold as described below.
CY2024Q4 asts Accrued Interest And Amortization Of Associated Debt Issuance Costs
AccruedInterestAndAmortizationOfAssociatedDebtIssuanceCosts
1300000
CY2024Q3 asts Gain Loss On Fair Value Adjustment Of Warrants
GainLossOnFairValueAdjustmentOfWarrants
236900000
asts Gain Loss On Fair Value Adjustment Of Warrants
GainLossOnFairValueAdjustmentOfWarrants
284800000
CY2023Q3 asts Gain Loss On Fair Value Adjustment Of Warrants
GainLossOnFairValueAdjustmentOfWarrants
7500000
asts Gain Loss On Fair Value Adjustment Of Warrants
GainLossOnFairValueAdjustmentOfWarrants
21500000
CY2024Q3 asts Warrant Liabilities
WarrantLiabilities
57500000
CY2023Q4 asts Warrant Liabilities
WarrantLiabilities
30000000
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
130700000
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6810000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2589000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20617000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10595000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7770421
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.11
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M3D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
769263
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
199395
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.36
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6801763
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.12
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y14D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5863333
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.03
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y11M19D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
6045907
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1809555
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.8
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
729372
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
7.13
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
141753
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.61
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
938430
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
Two types of equity awards have been granted under the 2020 Plan: (1) service-based options and (2) service-based and performance-based restricted stock units. Service-based options typically vest over a four year service period with 25% of the award vesting on the first anniversary of the employee’s commencement date, and the balance thereafter in 36 equal monthly installments. Service-based restricted stock units typically vest over a four year service period with 25% of the award vesting on each anniversary of the employee’s vesting commencement date. Performance-based restricted stock units typically vest on the earliest date that any of the following occurs: (i) the Company attains an incremental capital investment, or (ii) other specified performance conditions. Options typically expire no later than 10 years from the date of grant.
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.0021
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.0025
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.0053
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0028
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
asts Percentage Of Savings Required To Be Paid To Seller
PercentageOfSavingsRequiredToBePaidToSeller
0.85
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-303080000
us-gaap Profit Loss
ProfitLoss
-474234000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-131134000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-210008000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-171946000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-171946000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-264226000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-264226000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-50748000
us-gaap Profit Loss
ProfitLoss
-145553000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-29839000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-89918000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20909000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20909000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-55635000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-55635000
CY2020Q1 asts Maintenance Fee Payable
MaintenanceFeePayable
500000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-127101-index-headers.html Edgar Link pending
0000950170-24-127101-index.html Edgar Link pending
0000950170-24-127101.txt Edgar Link pending
0000950170-24-127101-xbrl.zip Edgar Link pending
asts-20240930.htm Edgar Link pending
asts-20240930.xsd Edgar Link pending
asts-ex10_3.htm Edgar Link pending
asts-ex31_1.htm Edgar Link pending
asts-ex31_2.htm Edgar Link pending
asts-ex32_1.htm Edgar Link pending
asts-ex32_2.htm Edgar Link pending
asts-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending